Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Net revenue $ 80,123 $ 70,451
Operating expenses:    
Cost of revenue [1] 19,527 21,033
Selling and marketing 18,066 20,540
Research and development 17,755 16,981
General and administrative 11,901 9,691
Depreciation and amortization 11,033 8,394
Restructuring and related 4,048 8,655
Total operating costs and expenses 82,330 85,294
Loss from operations (2,207) (14,843)
Other (expense) income, net:    
Change in fair value of warrant liabilities (1,058) (2,716)
Interest income (expense), net 895 (5)
Other income, net 60 187
Total other expense, net (103) (2,534)
Loss before income taxes (2,310) (17,377)
Income tax expense (260) (7,835)
Net loss $ (2,570) $ (25,212)
Net loss per share attributable to Class A and Class B common stockholders:    
Basic (USD per share) $ (0.02) $ (0.20)
Diluted (USD per share) $ (0.02) $ (0.20)
Weighted average shares of common stock outstanding:    
Basic (shares) 132,131 126,337
Diluted (shares) 132,131 126,337
[1] Amounts exclude depreciation and amortization.